Measured outcomes
The primary outcome assessed was: is surgeon or hospital volume associated with the rate of mitral valve repair in myxomatous degeneration. A secondary outcome evaluated was: is 30-day mortality associated with mitral valve repair in myxomatous degeneration, taking into account surgeon and or hospital volume.